Results 91 to 100 of about 36,401 (249)

Risk of new‐onset type 1 diabetes in individuals with celiac disease and thyroid disease—An observational study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims The objective of this study was to compare the risk of developing type 1 diabetes in individuals with celiac disease, hyperthyroidism and hypothyroidism to that of individuals without those conditions. Materials and Methods In this retrospective, observational, matched‐cohort study based on real‐world claims data, individuals with at ...
Steve V. Edelman, Daniel Agardh, Nancy Cui, Lichen Hao, Mattias Wieloch, Luigi Meneghini   +5 more
wiley   +1 more source

The impact of insulin pump therapy compared to multiple daily injections on complications and mortality in type 1 diabetes: A real‐world retrospective cohort study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Clinical trials have demonstrated the benefits of insulin pump therapy compared with multiple daily injections (MDI) in type 1 diabetes. However, contemporaneous real‐world data are limited. This study investigated the real‐world impact of insulin pump therapy compared with MDI. Materials and Methods A retrospective cohort study of adults
Sophie Haughton, David Riley, Simon Berry, Muhammad Fahad Arshad, Aikaterini Eleftheriadou, Matthew Anson, Yew Wen Yap, Daniel J. Cuthbertson, Rayaz A. Malik, Shazli Azmi, Uazman Alam, Ahmed Iqbal   +11 more
wiley   +1 more source

“The Proof is in the Pudding”: Do SGLT2 Inhibitors Cause Diabetic Ketoacidosis?

AACE Clinical Case Reports, 2018
Abbreviations: DKA diabetic ketoacidosis EuDKA euglycemic diabetic ketoacidosis SGLT2i sodium-glucose cotransporter 2 inhibitors T2DM type 2 diabetes ...
Elena Barengolts, MD
doaj  

Sick days glycaemic outcomes in a cohort of children and adolescents with type 1 diabetes using an AID system—A preliminary report

Diabetes, Obesity and Metabolism, EarlyView.
Davide Tinti, Cecilia Nobili, Gioia Bettin, Enrica Roggero, Alessandra Bondanese, Michela Trada, Alessia Gerace, Luisa de Sanctis   +7 more
wiley   +1 more source

The health economics of insulin therapy: How do we address the rising demands, costs, inequalities and barriers to achieving optimal outcomes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract The health economic value of insulin is usually expressed within a cost‐effectiveness framework providing an estimated incremental cost per quality‐adjusted life year (QALY) gained. Insulin clinical trials adopt a treat‐to‐target design in which both intervention and control arms aim to achieve similar levels of glycaemic control thereby ...
Phil McEwan, Marc Evans
wiley   +1 more source

Successful resuscitation in diabetic ketoacidosis: a strong case for the use of bicarbonate [PDF]

, 1974
N. G. Soler, Margaret Fitzgerald, Michael Bennett, J. M. Malins   +3 more
openalex   +1 more source

Serial correlation between saliva and blood beta‐hydroxybutyrate levels in children commencing the ketogenic diet for epilepsy

Epilepsia, EarlyView.
Abstract Objectives Accurate and user‐friendly methods to measure beta‐hydroxybutyrate (BHB) concentration are needed to guide the optimal use of ketogenic diet therapy (KDT). We aimed to determine the correlation between serum, capillary, and salivary BHB concentration, and to validate an electrochemical salivary BHB point‐of‐care test (POCT) in ...
Neha Kaul, Jing Duan, Dong Cui, Michael Erlichster, Zhibin Chen, Dovile Anderson, Jianxiong Chan, Ingrid E. Scheffer, Efstratios Skafidas, Jianxiang Liao, Patrick Kwan   +10 more
wiley   +1 more source

Cerebral oedema in diabetic ketoacidosis. [PDF]

, 1975
B. M. Frier, J. McConnell
openalex   +1 more source

The ‘nephrotoxins’ were stopped: what is in a name and its impact on kidney and cardiac health?

Internal Medicine Journal, EarlyView.
Abstract The term ‘nephrotoxin’ is often imprecisely applied to medications that are not inherently toxic to the kidneys, including renin‐angiotensin‐aldosterone system inhibitors, sodium‐glucose co‐transporter 2 inhibitors, diuretics and metformin. These drugs are frequently included in ‘sick day rules’ and may be prematurely discontinued during acute
Catherine Mao, Bobby Chacko
wiley   +1 more source

Insulin regimens for diabetic ketoacidosis. [PDF]

, 1977

openalex   +1 more source